SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-200594
Filing Date
2021-06-25
Accepted
2021-06-25 17:19:07
Documents
3
Period of Report
2021-06-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d172725d8k.htm 8-K 20271
2 EX-3.1 d172725dex31.htm EX-3.1 38581
3 EX-3.2 d172725dex32.htm EX-3.2 65301
  Complete submission text file 0001193125-21-200594.txt   125339
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40499 | Film No.: 211048992
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences